Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
42.62
1.07 (2.58%)
At close: Aug 15, 2025, 3:59 PM
43.44
1.92%
After-hours: Aug 15, 2025, 05:03 PM EDT

Kymera Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-275.43M -240.88M -223.86M -167.47M -157.85M -154.59M -146.96M -167.46M -157.59M -159.05M -154.81M -153.84M -139.42M -123.83M -100.22M -79M -58.41M -47.74M
Depreciation & Amortization
8.14M 7.96M 7.37M 6.24M 5.15M 4.15M 3.56M 3.49M 3.36M 3.17M 2.98M 2.85M 2.75M 2.6M 2.4M 2.21M 2.02M 1.86M
Stock-Based Compensation
58.35M 57.28M 55.01M 52.11M 48.86M 45.7M 43.12M 41.13M 38.55M 36.99M 35.48M 35.25M 33.57M 29.67M 24.97M 18.12M 13.05M 7.99M
Other Working Capital
8.43M -30.54M -26.33M -12.56M -2.24M 6.86M 644K -21.14M -36.85M -41.78M -39.49M -44.67M -53.34M -57.23M -64.16M -59.3M 92.03M 106.87M
Other Non-Cash Items
-11.57M 4.35M 22.15M 24.19M 17.44M -6.44M -23.05M -22.69M -14.88M -4.11M -1.61M 929K 5.17M 5.72M 5.83M 5.76M 4.19M 3.07M
Deferred Income Tax
n/a n/a n/a -17.82M -8.67M n/a n/a 17.82M 8.67M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-30.5M -44.98M -23.97M -8.53M 2.33M 8.34M 2.68M -22.7M -33.64M -36.26M -37.62M -39.59M -56.96M -60.59M -61.92M -57.75M 97.4M 112.18M
Operating Cash Flow
-251.01M -234.06M -194.5M -124.67M -106.13M -98.45M -102.83M -150.41M -153.03M -156.76M -153.09M -151.9M -154.89M -146.42M -128.95M -110.66M 58.27M 77.36M
Capital Expenditures
-1.91M -5.9M -12.84M -23.53M -31.79M -37.87M -34.48M -23.23M -16.4M -6.36M -2.84M -2.96M -2.02M -1.92M -1.6M -2.53M -4.64M -7.87M
Cash Acquisitions
n/a n/a n/a -30.58M -99.17M -145.77M -147.1M -115.63M -47.04M -82.97M -80.47M -75.56M -75.56M 6.98M 7.09M 1.28M 1.28M 1.28M
Purchase of Investments
-516.27M -562.18M -901.23M -868.31M -601.53M -550.02M -189.15M -290.88M -415.62M -427.69M -445.97M -463.13M -555.07M -520.51M -456.4M -360.45M -465.02M -509.39M
Sales Maturities Of Investments
522.34M 529.99M 499.27M 427.43M 397.83M 372.59M 363.52M 385.38M 405.29M 453.29M 469.33M 468.26M 459.88M 404.13M 358.17M 327.18M 236.39M 176.39M
Other Investing Acitivies
15.36M 33.57M 34.12M 64.7M 122.57M 148.84M 147.1M 115.63M 10.81M 46.74M 44.24M 39.32M 75.56M -6.98M -7.09M -1.28M -1.28M -1.28M
Investing Cash Flow
19.52M -24.86M -404.08M -453.69M -235.5M -215.31M 139.89M 71.27M -26.72M 19.24M 20.52M 2.17M -97.22M -118.3M -99.83M -35.81M -233.26M -340.86M
Debt Repayment
-1.59M -1.56M -1.58M -358K -57K -39K -76K -1.31M -1.26M -1.19M -1.13M -981K -1.04M -958K -849K -845K -602K -567K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
604.73M 606.49M 610.43M 11.76M 6.71M 6.58M 4.13M 5.38M 156.17M 155.17M 154.13M 154.11M 249.71M 250.86M 251.16M 248.94M 198.94M 197.19M
Financial Cash Flow
499.67M 255.35M 608.85M 608.02M 356.9M 356.79M 4.19M 4.21M 154.91M 153.97M 153M 153.1M 248.64M 249.87M 250.28M 248.5M 198.73M 196.74M
Net Cash Flow
268.18M -3.58M 10.24M 29.63M 15.24M 43.02M 41.25M -74.93M -24.84M 16.45M 20.43M 3.37M -3.46M -14.84M 21.5M 102.03M 23.73M -66.76M
Free Cash Flow
-252.92M -239.96M -207.34M -148.2M -137.92M -136.32M -137.31M -173.63M -169.43M -163.12M -155.92M -154.87M -156.92M -148.33M -130.54M -113.19M 53.63M 69.5M